Raiffeisen Bank International’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Raiffeisen Bank International's EW Position: Q2 2026 in Review
Raiffeisen Bank International increased its Edwards Lifesciences (EW) stake by 0.46% in Q2 2026, buying an estimated $112K and bringing the position to 289,788 shares worth $26.4M. The position accounts for 0.31% of the portfolio, ranked #76.
Raiffeisen Bank International first reported a position in EW in Q4 2024 and has held it in 7 quarters since. The position peaked at $26.7M in Q4 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Raiffeisen Bank International held 289,788 shares of Edwards Lifesciences worth $26.4M as of Q2 2026.
- Raiffeisen Bank International bought 1,333 Edwards Lifesciences shares in Q2 2026, an estimated $112K.
- Edwards Lifesciences made up 0.31% of Raiffeisen Bank International's portfolio in Q2 2026, its #76 holding.
- Raiffeisen Bank International first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
- Raiffeisen Bank International's Edwards Lifesciences position peaked at $26.7M in Q4 2025.
- 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.